Share this Article
You are free to share this article under the Attribution 4.0 International license.
A new method for interpreting brain waves could potentially help determine the best depression treatment, according to a new study.
The researchers used electroencephalography, a tool for monitoring electrical activity in the brain, and an algorithm to identify a brain-wave signature in individuals with depression who will most likely respond to sertraline, an antidepressant marketed as Zoloft.
The study emerged from a decades-long effort to create biologically based approaches, such as blood tests and brain imaging, to help personalize the treatment of depression and other mental disorders. Currently, there are no such tests to objectively diagnose depression or guide its treatment.
This study takes previous research showing that we can predict who benefits from an antidepressant and actually brings it to the point of practical utility, says Amit Etkin, professor of psychiatry and behavioral sciences at Stanford University. I will be surprised if this isnt used by clinicians within the next five years.
Instead of functional magnetic resonance imaging, an expensive technology often used in studies to image brain activity, the scientists turned to electroencephalography, or EEG, a much less costly technology.
The paper is one of several based on data from a federally funded depression study launched in 2011the largest randomized, placebo-controlled clinical trial on antidepressants ever conducted with brain imagingwhich tested the use of sertraline in 309 medication-free patients.
The trial was called Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care, or EMBARC. The researchers designed the trial to advance the goal of improving the trial-and-error method of treating depression that is still in use today.
It often takes many steps for a patient with depression to get better, says co-senior author Madhukar Trivedi, professor of psychiatry at the University of Texas-Southwestern who led the research team.
We went into this thinking, Wouldnt it be better to identify at the beginning of treatment which treatments would be best for which patients?'
Major depression is the most common mental disorder in the United States, affecting about 7% of adults in 2017, according to the National Institute of Mental Health (NIMH). Among those, about half never get diagnosed.
For those who do, finding the right treatment can take years, Trivedi says. He points to one of his past studies that showed only about 30% of patients with depression saw any remission of symptoms after their first treatment with an antidepressant.
Current methods for diagnosing depression are simply too subjective and imprecise to guide clinicians in quickly identifying the right treatment, Etkin says. In addition to a variety of antidepressants, there are several other types of treatments for depression, including psychotherapy and brain stimulation, but figuring out which treatment will work for which patients is based on educated guessing.
To diagnose depression, clinicians rely on a patient reporting at least 5 of 9 common symptoms of the disease. The list includes symptoms such as feelings of sadness or hopelessness, self-doubt, sleep disturbancesranging from insomnia to sleeping too muchlow energy, unexplained body aches, fatigue, and changes in appetite, ranging from overeating to undereating. Patients often vary in both the severity and types of symptoms they experience, Etkin says.
As a psychiatrist, I know these patients differ a lot, Etkin says. But we put them all under the same umbrella, and we treat them all the same way.
Treating people with depression often begins with prescribing them an antidepressant. If one doesnt work, a second antidepressant is prescribed. Each of these trials often takes at least eight weeks to assess whether the drug worked and symptoms are alleviated.
If an antidepressant doesnt work, other treatments, such as psychotherapy or occasionally transcranial magnetic stimulation, may work. Often, doctors combine multiple treatments, Etkin says, but figuring out which combination works can take a while.
People often feel a lot of dejection each time a treatment doesnt work, creating more self-doubt for those whose primary symptom is most often self-doubt, Trivedi says.
The EMBARC trial enrolled 309 people with depression who randomly received either sertraline or a placebo.
For their study, Etkin and his colleagues set out to find a brain-wave pattern to help predict which depressed participants would respond to sertraline. First, the researchers collected EEG data on the participants before they received any drug treatment. The goal was to obtain a baseline measure of brain-wave patterns.
Next, using insights from neuroscience and bioengineering, the investigators analyzed the EEG using a novel artificial intelligence technique they developed and identified signatures in the data that predicted which participants would respond to treatment based on their individual EEG scans.
The researchers found that this technique reliably predicted which of the patients did, in fact, respond to sertraline and which responded to placebo. They replicated the results at four different clinical sites.
Further research suggests that participants who researchers predicted would show little improvement with sertraline were more likely to respond to treatment involving transcranial magnetic stimulation, or TMS, in combination with psychotherapy.
Using this method, we can characterize something about an individual persons brain, Etkin says. Its a method that can work across different types of EEG equipment, and thus more apt to reach the clinic.
Part of getting these study results used in clinical care is, I think, that society has to demand it, Trivedi says. That is the way things get put into practice. I dont see a downside to putting this into clinical use soon.
When researchers launched EMBARC, it was part of a broader effort by the NIMH to push for improvements in mental health care by using advances in fields such as genetics, neuroscience, and biotechnology, says Thomas Insel, who served as director of that institute from 2002 to 2015.
We went into EMBARC saying anything is possible, Insel says. Lets see if we can come up with clinically actionable techniques. He didnt think it would take this long, but he remains optimistic.
I think this study is a particularly interesting application of EMBARC, he says. It leverages the power of modern data science to predict at the individual level who is likely to respond to an antidepressant.
In addition to improving care, the researchers say they see a possible side benefit to the use of biologically based approaches: It could reduce the stigma associated with depression and other mental health disorders that prevents many people from seeking appropriate medical care.
Id love to think scientific evidence will help to counteract this stigma, but it hasnt so far, says Insel. Its been over 160 years since Abraham Lincoln says that melancholy is a misfortune, not a fault. We still have a long way to go before most people will understand that depression is not someones fault. (President Lincoln suffered bouts of depression.)
A paper on the work appears in Nature Biotechnology. Additional researchers from South China University of Technology, the Netherlands Research Institute, Harvard Medical School, the New York State Psychiatric Institute, Columbia University, and the Netherlands neuroCare Group contributed to the work.
Etkin is on leave from Stanford, working as the founder and CEO of the startup Alto Neuroscience, a company based in Los Altos, California that aims to build on these findings and develop a new generation of biologically based diagnostic tests to personalize mental health treatments with a high degree of clinical utility. Insel is an investor in Alto Neuroscience.
Funding came from the National Institutes of Health, the Stanford Neurosciences Institute, the Hersh Foundation, the National Key Research and Development Plan of China, and the National Natural Science Foundation of China.
Source: Stanford University
Read the original post:
Brain waves show who'll respond to Zoloft - Futurity: Research News
- Worlds first crowd-sourced neuroscience study aims to understand how our brains predict the future - EurekAlert - March 15th, 2025 [March 15th, 2025]
- Rewriting Neuroscience: Possible Foundations of Human Intelligence Observed for the First Time - SciTechDaily - March 15th, 2025 [March 15th, 2025]
- Calculating neurosciences carbon cost: Q&A with Stefan Pulver and William Smith - The Transmitter: Neuroscience News and Perspectives - March 15th, 2025 [March 15th, 2025]
- The future of neuroscience research at U.S. minority-serving institutions is in danger - The Transmitter: Neuroscience News and Perspectives - March 15th, 2025 [March 15th, 2025]
- Dopamine and social media: Why you cant stop scrolling, according to neuroscience - PsyPost - March 15th, 2025 [March 15th, 2025]
- Neuroscience Discovered a Clever Trick for Squeezing More Joy Out of Everyday Pleasures - Inc. - March 15th, 2025 [March 15th, 2025]
- The limits of neuroscience - The Transmitter: Neuroscience News and Perspectives - March 15th, 2025 [March 15th, 2025]
- BPOM Explains The Benefits Of Fasting From The Health And Neuroscience Side - VOI English - March 15th, 2025 [March 15th, 2025]
- How tiny tardigrades could help tackle systems neuroscience questions - The Transmitter: Neuroscience News and Perspectives - March 15th, 2025 [March 15th, 2025]
- Alison Preston explains how our brains form mental frameworks for interpreting the world - The Transmitter: Neuroscience News and Perspectives - March 15th, 2025 [March 15th, 2025]
- The Mystical Mind Meets Neuroscience: Seeking the Roots of Consciousness - Next Big Idea Club Magazine - March 15th, 2025 [March 15th, 2025]
- Myosin Therapeutics Closes Second Seed Round to Advance Clinical Trials for Innovative Cancer and Neuroscience Therapies - PR Newswire - March 5th, 2025 [March 5th, 2025]
- Neuroscience Ph.D. programs adjust admissions in response to U.S. funding uncertainty - The Transmitter: Neuroscience News and Perspectives - March 5th, 2025 [March 5th, 2025]
- New tools help make neuroimaging accessible to more researchers - The Transmitter: Neuroscience News and Perspectives - March 5th, 2025 [March 5th, 2025]
- Future Thinking Training Reduces Impulsivity - Neuroscience News - March 5th, 2025 [March 5th, 2025]
- Null and Noteworthy, relaunched: Probing a schizophrenia biomarker - The Transmitter: Neuroscience News and Perspectives - March 5th, 2025 [March 5th, 2025]
- How to communicate the value of curiosity-driven research - The Transmitter: Neuroscience News and Perspectives - March 5th, 2025 [March 5th, 2025]
- Cognitive neuroscience approach to explore the impact of wind turbine noise on various mental functions - Nature.com - March 5th, 2025 [March 5th, 2025]
- Football on the Brain: Helping coaches embed neuroscience knowledge - Training Ground Guru - March 5th, 2025 [March 5th, 2025]
- Taking Control: Using Neuroscience to Build Better Lives - theLoop - March 5th, 2025 [March 5th, 2025]
- Creating a pipeline of talent to feed the growth of Neuroscience: Lessons from Ghana - Myjoyonline - March 5th, 2025 [March 5th, 2025]
- Exclusive: NIH appears to archive policy requiring female animals in studies - The Transmitter: Neuroscience News and Perspectives - February 25th, 2025 [February 25th, 2025]
- Roll On Down The Highway 2025 Tour coming to Neuroscience Group Field - WeAreGreenBay.com - February 25th, 2025 [February 25th, 2025]
- STEM organizations host Neuroscience Outreach Fair for local K-12 students - University of Virginia The Cavalier Daily - February 25th, 2025 [February 25th, 2025]
- Adapt or die: Safeguarding the future of diversity and inclusion funding in neuroscience - The Transmitter: Neuroscience News and Perspectives - February 25th, 2025 [February 25th, 2025]
- The last two-author neuroscience paper? - The Transmitter: Neuroscience News and Perspectives - February 25th, 2025 [February 25th, 2025]
- Gate Neurosciences Strengthens Focus on the Synapse as a Therapeutic Target with Acquisition of Boost Neuroscience - Business Wire - February 25th, 2025 [February 25th, 2025]
- Why Firefly Neuroscience, Inc. (AIFF) Is Soaring This Year So Far - Yahoo Finance - February 25th, 2025 [February 25th, 2025]
- Breaking the barrier between theorists and experimentalists - The Transmitter: Neuroscience News and Perspectives - February 25th, 2025 [February 25th, 2025]
- Preserving Brain Health and Advancing Neuroscience - University of Miami - February 25th, 2025 [February 25th, 2025]
- Science must step away from nationally managed infrastructure - The Transmitter: Neuroscience News and Perspectives - February 25th, 2025 [February 25th, 2025]
- Repurposed Blood Pressure Drug May Treat ADHD - Neuroscience News - February 25th, 2025 [February 25th, 2025]
- How to teach students about science funding - The Transmitter: Neuroscience News and Perspectives - February 25th, 2025 [February 25th, 2025]
- Reflecting on 2024: Advancing Neuroscience Research to Improve Neurological Health - National Institute of Neurological Disorders and Stroke - February 25th, 2025 [February 25th, 2025]
- Brains Hidden Circuitry for Risk and Reward Uncovered - Neuroscience News - February 25th, 2025 [February 25th, 2025]
- Why We Keep Exploring Even After Learning the Best Strategy - Neuroscience News - February 25th, 2025 [February 25th, 2025]
- Unlocking Cellular Youth: The Protein That Reverses Aging - Neuroscience News - February 25th, 2025 [February 25th, 2025]
- This paper changed my Life: Bill Newsome reflects on a quadrilogy of classic visual perception studies - The Transmitter: Neuroscience News and... - February 25th, 2025 [February 25th, 2025]
- Roundup: The false association between vaccines and autism - The Transmitter: Neuroscience News and Perspectives - February 3rd, 2025 [February 3rd, 2025]
- Static pay, shrinking prospects fuel neuroscience postdoc decline - The Transmitter: Neuroscience News and Perspectives - February 3rd, 2025 [February 3rd, 2025]
- Stimulating the brain with Damien Fair - The Transmitter: Neuroscience News and Perspectives - February 3rd, 2025 [February 3rd, 2025]
- Unhealthy Diet Linked to Faster Biological Aging in Young Adults - Neuroscience News - February 3rd, 2025 [February 3rd, 2025]
- Bob Smittcamp Family Neuroscience Institute coming to Fresno in 2026 - ABC30 News - February 3rd, 2025 [February 3rd, 2025]
- Norton Neuroscience Institute selected to pilot national Brain Health Navigator program - Norton Healthcare - February 3rd, 2025 [February 3rd, 2025]
- Coding bonus: Bats hippocampal cells log spatial, social cues - The Transmitter: Neuroscience News and Perspectives - February 3rd, 2025 [February 3rd, 2025]
- ADHD and brainwaves: How neuroscience is changing the way we diagnose the condition - PsyPost - February 3rd, 2025 [February 3rd, 2025]
- David Robbe challenges conventional notions of time and memory - The Transmitter: Neuroscience News and Perspectives - February 3rd, 2025 [February 3rd, 2025]
- How the Brain Processes Space and Time - Neuroscience News - February 3rd, 2025 [February 3rd, 2025]
- Using neuroscience to help establish healthier habits | Opinion - South Bend Tribune - February 3rd, 2025 [February 3rd, 2025]
- Solvonis chairman on heavy-hitting M&A in neuroscience sector - ICYMI - Proactive Investors UK - February 3rd, 2025 [February 3rd, 2025]
- New neuroscience research sheds light on distinct patterns of learning and generalization in autistic adults - PsyPost - January 23rd, 2025 [January 23rd, 2025]
- Neuroscientists need to do better at explaining basic mental health research - The Transmitter: Neuroscience News and Perspectives - January 23rd, 2025 [January 23rd, 2025]
- How Severance shows the possibilities of cognitive neuroscience - Fast Company - January 23rd, 2025 [January 23rd, 2025]
- AdventHealth Welcomes New Leadership In Heart and Vascular Services, Neuroscience and Orthopedics - Northwest Georgia News - January 23rd, 2025 [January 23rd, 2025]
- School of Neuroscience and Language Sciences Program recognized with University Exemplary Department or Program Award - Virginia Tech - January 23rd, 2025 [January 23rd, 2025]
- Early Exposure to Violent Media Linked to Teen Antisocial Behavior - Neuroscience News - January 23rd, 2025 [January 23rd, 2025]
- The Real Cognitive Neuroscience Behind Severance - WIRED - January 23rd, 2025 [January 23rd, 2025]
- The 15 most popular psychology and neuroscience studies in 2024 - PsyPost - January 1st, 2025 [January 1st, 2025]
- The 'lizard brain' lie: How neuroscience demolished the greatest mind myth - BBC Science Focus - January 1st, 2025 [January 1st, 2025]
- Revolutionizing Brain Diagnostics with Light and AI - Neuroscience News - January 1st, 2025 [January 1st, 2025]
- How Early Experiences Shape Genes, Brain Health, and Resilience - Neuroscience News - January 1st, 2025 [January 1st, 2025]
- A nation exhausted: The neuroscience of why Americans are tuning out political news - Indiana Capital Chronicle - January 1st, 2025 [January 1st, 2025]
- Lithium Restores Brain Function and Behavior in Autism - Neuroscience News - January 1st, 2025 [January 1st, 2025]
- Partners in Diversity presents the science of belonging: exploring the neuroscience of inclusion - Here is Oregon - January 1st, 2025 [January 1st, 2025]
- Classical vs. Operant Conditioning: The Brain's Memory Tug-of-War - Neuroscience News - January 1st, 2025 [January 1st, 2025]
- The Personality Gap Between Singles and the Partnered - Neuroscience News - January 1st, 2025 [January 1st, 2025]
- The Neuroscience Behind Vermeers Girl and Its Hypnotic Power - ZME Science - January 1st, 2025 [January 1st, 2025]
- Serotonin, GABA, and Dopamine Drive Hunger and Feeding - Neuroscience News - December 23rd, 2024 [December 23rd, 2024]
- A nation exhausted: The neuroscience of why Americans are tuning out politics - The Conversation - December 23rd, 2024 [December 23rd, 2024]
- UNO Goalie and Neuroscience Grad Shines in Her Athletic and Academic Aspirations - University of Nebraska Omaha - December 23rd, 2024 [December 23rd, 2024]
- Neuroscience Major Seeks to Bridge the Generation Gap, Help Alzheimers Patients - Pomona College - December 23rd, 2024 [December 23rd, 2024]
- Spectrum 2024: Year in review - The Transmitter: Neuroscience News and Perspectives - December 23rd, 2024 [December 23rd, 2024]
- Say what? The Transmitters top quotes of 2024 - The Transmitter: Neuroscience News and Perspectives - December 23rd, 2024 [December 23rd, 2024]
- Targeted or Broadcast? How the Brain Processes Visual Information - Neuroscience News - December 23rd, 2024 [December 23rd, 2024]
- 70 Is the New 60: Age Related Declines Slowing in Older People - Neuroscience News - December 23rd, 2024 [December 23rd, 2024]
- Breathing Rhythms During Sleep Strengthen Memory Consolidation - Neuroscience News - December 23rd, 2024 [December 23rd, 2024]
- How our brains think: Exploring the world of neuroscience at the Yale Peabody Museum - Connecticut Public - December 23rd, 2024 [December 23rd, 2024]
- Assembloids illuminate circuit-level changes linked to autism, neurodevelopment - The Transmitter: Neuroscience News and Perspectives - December 23rd, 2024 [December 23rd, 2024]
- Mapping the Brain's Response to Social Rejection - Neuroscience News - December 9th, 2024 [December 9th, 2024]
- An eye for science: Q&A with Bryan W. Jones - The Transmitter: Neuroscience News and Perspectives - December 9th, 2024 [December 9th, 2024]